{"resourceType":"Medication","id":"61e0e5b8-a20f-5a51-87e2-3e8730d0213a","meta":{"versionId":"1","lastUpdated":"2022-05-24T15:13:38.714-04:00","source":"#Xos4h4xCIRIDlwBn","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-medication"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Temporary narrative for medication mix</b></p></div>"},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/medication-mix","value":"Bevacizumab (Avastin)--BEVA400I--50242006101_0.9% Sodium Chloride--NS100--00338004938"}],"ingredient":[{"itemReference":{"reference":"Medication/04028c38-88c3-5e86-97d4-60837e9cd0d2"}},{"itemReference":{"reference":"Medication/2b2d3a39-ca72-5dfc-a66f-e13c931529c8"}}]}